Evaluation of physical activity in cancer patients receiving radiation therapy
PO-2303
Abstract
Evaluation of physical activity in cancer patients receiving radiation therapy
Authors: Hilal Alkış1, Hatice Kübra Gündüz1, Aleksei Kornienko1, Gülşah Özden1, Melisa Bağcı Kılıç1, Serpil Çeçen2
1Marmara University, Radiation Oncology, İstanbul, Turkey; 2University of Health Sciences, Physiology, İstanbul, Turkey
Show Affiliations
Hide Affiliations
Purpose or Objective
Physical activity (PA) is associated with cancer risk, recurrence, and prognosis, and has an important role in cancer prevention. The aim of the study is to investigate the PA of cancer patients receiving radiation therapy (RT).
Material and Methods
A total of 46 patients were included in the study. Male to female ratio was 1.9/1. Patients were designed according to their primary malignancies as five groups; lung (n=17), rectal (n =14), gastric (n=6), esophageal (n=4), and other malignancies i.e. pancreatic, hepatobiliary, and gallbladder (n=5). International Physical Activity Questionnaire-Short Form (IPAQ-SF) was used for the assessment of PA. Questionnaires were administered on the first day of RT. PA of patients was classified as high (>3000), moderate (>600 to ≤3000), and low (≤600) according to total-PA scores.
Results
Median age of the patients was 62 years (34-77). Patients with low, moderate and high PA scores were 56.5% (26), 39.1 % (n=18), and 4.4% (n=2), respectively. The majority of the lung cancer patients were with low PA scores (71%, n=12) and all of the esophageal cancer patients were with low PA scores. Rectal cancer patients had better PA scores; 8 had moderate and 1 had high scores, and 5 patients (36%) were with low PA scores. Three patients with gastric cancer had low scores and 3 had moderate. Two patients with high PA scores were diagnosed with lung and rectal cancer.
Conclusion
The majority of the cancer patients were minimally active; especially esophageal and lung cancer patients were more likely to have low PA. Evaluation of PA in cancer patients may be taken into interest for both improving prognosis and better supportive care.